STE · earnings call history
STERIS plc Q1 FY27 — Strong Organic Growth and Major Investment in Formulated Chemistry
Read the briefSTERIS Q4 FY26 — Record Year with Strong Revenue and EPS Growth
Read the briefBrowse all US companies on the earnings-call register.